AGP Executive Report
Last update: an hour agoPancreatic Cancer Breakthrough: A new once-daily experimental pill, daraxonrasib, nearly doubles survival for advanced pancreatic cancer patients in a phase 3 trial, with a median 13.2 months versus about 6.6–6.7 months on standard chemotherapy, plus fewer serious side effects and improved quality of life—results presented at ASCO and published in the New England Journal of Medicine. Medicaid Work Requirements Pressure: States are pushing back on Medicaid work requirements as costs rise and budgets tighten, including Arizona’s negotiations over funding to implement the policy. Arizona STEM & Clean Energy: Southern Utah University’s engineering team won first in the design challenge and placed second overall at a national hydropower competition, showing how classroom engineering is turning into real-world clean-energy problem solving. Local Tech/Infrastructure: Phoenix Sky Harbor is expanding its Vehicle Movement Area Transponder program, adding 85 units to improve airfield safety and coordination. AI Safety Watch: A new test found some major AI tools can generate altered Bangladeshi national ID images without clear warnings, raising concerns for identity verification systems. Education Dispute: The EVIT transportation fight with East Valley districts is escalating, with parents worried about access to Mesa career and technical education classes. Arizona Research: ASU researchers report fog can host living bacteria that may actively process air pollutants, reframing fog as a living habitat rather than just droplets.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
